Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for m ozanimod to a specific field?

Approximate Matches

2367
Any Name

2353
Standardized Name

1214
Reference Text / Citation

496
Display Name

346
Note

203
Reference URL

151
Related Substance Name

76
Organism Author

63
Relationship Comments

47
Mixture Component Name

30
root_modifications_structuralModifications_molecularFragment_refPname

28
Code Literal

22
Code Comments

17
root_modifications_structuralModifications_residueModified

17
Protein Structural Modification Residue

16
WIKIPEDIA

15
Code URL

9
Structure Stereo Comments

8
ALANWOOD

5
Protein Structural Modification Substance Name

Showing 3841 - 3850 of 4710 results

First page
Previous page
Next page
Next page

CLOSTRIDIUM BUTYRICUM

Q3NN3EB8VY

Status:

Possibly Marketed Outside US

Source:

NCT03857425: Phase 4 Interventional Completed Gastritis

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03857425

Class:

STRUCTURALLY DIVERSE

P-PRF

5A6EO27RQD

Status:

Possibly Marketed Outside US

Source:

NCT04016376: Phase 4 Interventional Active, not recruiting Breast Cancer

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04016376

Class:

STRUCTURALLY DIVERSE

MYCOBACTERIUM BOVIS BCG

D3GOY6203T

Status:

Possibly Marketed Outside US

Source:

UK NHS:Mycobacterium bovis BCG

Source URL:

https://tripod.nih.gov/npc/#Download

Class:

STRUCTURALLY DIVERSE

THERIDION CURASSAVICUM

9Z8D3HEM8L

Status:

Possibly Marketed Outside US

Source:

Canada:THERIDION

Source URL:

https://tripod.nih.gov/npc/#Download

Class:

STRUCTURALLY DIVERSE

URTICA URENS WHOLE

IHN2NQ5OF9

Status:

Possibly Marketed Outside US

Source:

Canada:URTICA URENS

Source URL:

https://tripod.nih.gov/npc/#Download

Class:

STRUCTURALLY DIVERSE

Silicified Microcrystalline Cellulose (65 µm)

K2EZE348C4

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S

Class:

G1 SPECIFIED SUBSTANCE

Tosylamide/Formaldehyde Resin (80% n-Butyl acetate dispersion)

7D4DLW89CB

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

HLA class I COVID-19 peptide targets

D9QD5G5TPX

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

Rebaudioside M 85%

X3YJ76S94Z

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

MATRIX-M1 ADJUVANT

YZ7P8Y8ECX

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

Structurally Diverse

CLOSTRIDIUM BUTYRICUM

Structurally Diverse

P-PRF

Structurally Diverse

MYCOBACTERIUM BOVIS BCG

Structurally Diverse

THERIDION CURASSAVICUM

Structurally Diverse

URTICA URENS WHOLE

Concept

Silicified Microcrystalline Cellulose (65 µm)

7D4DLW89CB
Not a public record

Concept

Tosylamide/Formaldehyde Resin (80% n-Butyl acetate dispersion)

D9QD5G5TPX
Not a public record

Concept

HLA class I COVID-19 peptide targets

X3YJ76S94Z
Not a public record

Concept

Rebaudioside M 85%

YZ7P8Y8ECX
Not a public record

Concept

MATRIX-M1 ADJUVANT

Showing 3841 - 3850 of 4710 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1